awards grant
- A double-blind placebo-controlled trial of an HLA-restricted, allergen-derived T cell peptide vaccine in cat-allergic asthma
- Investigating the regulatory T-cell mechanisms associated with successful peptide-based immunotherapy (PIT) of cat-allergic asthmatic subjects
- T cell vaccines for asthma and allergic rhinitis